Interval estimation

ITF unveils new research into gender equality in sport

Retrieved on: 
Monday, April 12, 2021

To make a positive impact in this area, it is vital that we have a credible understanding of media and social media language.

Key Points: 
  • To make a positive impact in this area, it is vital that we have a credible understanding of media and social media language.
  • The results reveal that, despite similar public appetite across both men\'s and women\'s tennis, there is a distinct difference in the narrative surrounding them.
  • Comparative analysis between male and female athletes was undertaken on a sample of 25,000 online posts per gender, per sport, per year, per language/country.
  • All relative differences between male and female players are statistically significant at the 99% confidence interval.\nSearch analysis was conducted using Google, incognito.\n'

ITF unveils new research into gender equality in sport

Retrieved on: 
Monday, April 12, 2021

To make a positive impact in this area, it is vital that we have a credible understanding of media and social media language.

Key Points: 
  • To make a positive impact in this area, it is vital that we have a credible understanding of media and social media language.
  • The results reveal that, despite similar public appetite across both men\'s and women\'s tennis, there is a distinct difference in the narrative surrounding them.
  • Comparative analysis between male and female athletes was undertaken on a sample of 25,000 online posts per gender, per sport, per year, per language/country.
  • All relative differences between male and female players are statistically significant at the 99% confidence interval.\nSearch analysis was conducted using Google, incognito.\n'

Superiority of Orsiro over Xience Demonstrated in STEMI Patients: Late-Breaking Data at ESC

Retrieved on: 
Tuesday, September 3, 2019

"Based on the data, compared to the Xience stent, Orsiro is a superior solution for STEMI patients.

Key Points: 
  • "Based on the data, compared to the Xience stent, Orsiro is a superior solution for STEMI patients.
  • Orsiro demonstrated superiority in the clinical primary endpoint of TLF5 with an incidence of 4%, in comparison to Xience, with an incidence of 6% at 12months (Rate Ratio 0.59, 95% Bayesian credible interval, 0.37-0.94; posterior probability of superiority, 98.6%).
  • The difference in TLF was driven by lower rates of clinically-indicated target lesion revascularization in patients treated with ultrathin Orsiro compared to Xience.
  • "The BIOSTEMI results are groundbreaking.Our data demonstrates a 41%6 lower risk for TLF with Orsiro, delivering a significant benefit for interventionalists and their STEMI patients."

KORE Appoints Scott Trebilcock as President and Chief Executive Officer

Retrieved on: 
Thursday, July 4, 2019

Imperial Mineral Historical Resource Estimation Parameters: a) Grade estimation is based on assay samples composited to 20ft intervals.

Key Points: 
  • Imperial Mineral Historical Resource Estimation Parameters: a) Grade estimation is based on assay samples composited to 20ft intervals.
  • c) The database for the Imperial model consisted of 349 RC holes totalling 190,134 feet of drilling.
  • Mineral resources were reported within an optimized pit shell using a gold price of US$1,400/oz with a process recovery of 80%.
  • The estimate of mineral resources may be materially affected by environmental,
    them to an Indicated or Measured mineral resource category.

The Potential Role of the J-Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science | ACCP/CSRC Position Paper

Retrieved on: 
Tuesday, April 2, 2019

Dr. Michael J. Fossler, Jr emphasized, "This important paper demonstrates the potential value of the J-Tpeak interval, which may be a more discerning marker of pro-arrhythmic potential than the QTc interval.

Key Points: 
  • Dr. Michael J. Fossler, Jr emphasized, "This important paper demonstrates the potential value of the J-Tpeak interval, which may be a more discerning marker of pro-arrhythmic potential than the QTc interval.
  • Very soon, new drug developers may be able to use this technique to develop safer pharmaceuticals for patients.
  • To date, QT interval prolongation has been considered to be an imperfect but nonetheless informative proarrhythmic liability biomarker.
  • More recently, attention has focused on another ECG interval, the heart rate-corrected J-Tpeak interval, hoping that it may prove to be a more discerning biomarker of true proarrhythmic liability.